These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A CLINICAL EVALUATION OF ZEASORB POWDER IN PODIATRY. WEINSTOCK BS J Am Podiatry Assoc; 1965 May; 55():350. PubMed ID: 14324337 [No Abstract] [Full Text] [Related]
3. Use of tolnaftate powder in the treatment and prophylaxis of foot mycoses. Balogh E; Nagy E; Mészáros C Ther Hung; 1988; 36(2):86-7. PubMed ID: 3201392 [No Abstract] [Full Text] [Related]
4. Tolnaftate powder in prophylaxis of tinea pedis. Smith EB; Dickson JE; Knox JM South Med J; 1974 Jul; 67(7):776-8. PubMed ID: 4600407 [No Abstract] [Full Text] [Related]
5. Prophylaxis of tinea pedis. Efficacy of tolnaftate powder and its talc-cornstarch base. Burrill BB; Nemlick AS J Med Soc N J; 1970 Oct; 67(10):629-31. PubMed ID: 4920842 [No Abstract] [Full Text] [Related]
6. Comparison between undecylenic acid and tolnaftate in the treatment of tinea pedis. Fuerst JF; Cox GF; Weaver SM; Duncan WC Cutis; 1980 May; 25(5):544-6, 549. PubMed ID: 6991217 [TBL] [Abstract][Full Text] [Related]
7. 2% Miconazole nitrate powder in aerosol spray form: its efficacy in treating tinea pedis. Shellow WV J Int Med Res; 1982; 10(1):28-31. PubMed ID: 7060822 [TBL] [Abstract][Full Text] [Related]
8. [DYSHIDROSES CAUSED BY KAUFMANN-WOLF FUNGI AND MYCOSES DUE TO TRICHOPHYTUM RUBRUM]. GERENCSER N Dermatol Wochenschr; 1964 Feb; 149():147-51. PubMed ID: 14162440 [No Abstract] [Full Text] [Related]
9. COMPARATIVE STUDY OF TOLNAFTATE SOLUTION AND COMPOUND UNDECYLENIC ACID OINTMENT N.F. IN THE TREATMENT OF EPIDERMOPHYTOSES. LUBOWE II; WEXLER L Curr Ther Res Clin Exp; 1965 Jul; 7():401-5. PubMed ID: 14314512 [No Abstract] [Full Text] [Related]
10. [Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis]. Yamaguchi H; Uchida K; Tanaka T; Yamaguchi T Jpn J Antibiot; 2001 Jun; 54(6):323-30. PubMed ID: 11521512 [TBL] [Abstract][Full Text] [Related]
11. Comparison of over-the-counter agents for tinea pedis. Tschen EH; Becker LE; Ulrich JA; Hoge WH; Smith EB Cutis; 1979 May; 23(5):696-8. PubMed ID: 378561 [TBL] [Abstract][Full Text] [Related]
12. Tolnaftate as a prophylactic agent for tinea pedis. Charney P; Torres VM; Mayo AW; Smith EB Int J Dermatol; 1973; 12(3):179-85. PubMed ID: 4704166 [No Abstract] [Full Text] [Related]
13. Studies in the epidemiology of tinea pedis. VI. Tinea pedis in a boy's boarding-school. ENGLISH MP; GIBSON MD; WARIN RP Br Med J; 1961 Apr; 1(5232):1083-6. PubMed ID: 13696901 [No Abstract] [Full Text] [Related]
14. Drugs for athlete's foot and tinea cruris. Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605 [No Abstract] [Full Text] [Related]
15. Tolnaftate in the treatment of superficial mycotic infections. Vibhatavanija T; Phanich V; Thianprasit M; Youngchaiyud U Southeast Asian J Trop Med Public Health; 1972 Jun; 3(2):277-9. PubMed ID: 4563192 [No Abstract] [Full Text] [Related]
16. A controlled study of haloprogin and tolnaftate in tinea pedis. Carter VH Curr Ther Res Clin Exp; 1972 Jun; 14(6):307-10. PubMed ID: 4625803 [No Abstract] [Full Text] [Related]
17. Tinea pedis. CALNAN CD Med World; 1956 Feb; 84(2):117-9. PubMed ID: 13296607 [No Abstract] [Full Text] [Related]
18. Tinea pedis in adolescence. MUNRO-ASHMAN D Proc R Soc Med; 1962 Jul; 55(7):551-4. PubMed ID: 14477243 [No Abstract] [Full Text] [Related]